Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 8Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma 6Myelodysplastic Syndromes 4Multiple Myeloma 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasms, Plasma Cell 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 2Myeloproliferative Disorders 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid 2Leukemia, Biphenotypic, Acute 2Hematologic Diseases 2Congenital Abnormalities 2Thrombocythemia, Essential 1Shwachman-Diamond Syndrome 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1Primary Myelofibrosis 1Preleukemia 1Precancerous Conditions 1Polycythemia Vera 1Osteosarcoma 1Neuroblastoma 1Neoplasms by Histologic Type 1

Interventions

fludarabine 7Tacrolimus 6Cyclophosphamide 6Whole-Body Irradiation 5Mycophenolic Acid 5Busulfan 5fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 4Imatinib Mesylate 4Cytarabine 4Sirolimus 3Melphalan 3thymoglobulin 2asciminib 2Thiotepa 2Patient Reported Outcome Measures 2Mesna 2Bone Marrow Transplantation 2Antilymphocyte Serum 2venetoclax 1ponatinib 1pegfilgrastim 1nilotinib 1nicotinamide-beta-riboside 1methanesulfonic acid 1lonafarnib 1lestaurtinib 1glasdegib 1flumatinib 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Myeloid × Bone Marrow Transplantation × Clear all
NCT03779854 2026-05-14

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Recruiting
68 enrolled
LymphoidMyeloidOther hematologic neoplasm

GATA2 Deficiency, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Leukemia, Mast-Cell, Leukemia, Myeloid, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04904588 2026-03-18

ACCESS

Center for International Blood and Marrow Transplant Research

Phase 2 Active not recruiting
300 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasm

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Precancerous Conditions, Preleukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡